Shares of Caris Life Sciences soared in their public debut Wednesday, as investors bought into the company’s business of molecular profiling and drug research using artificial intelligence.
www.marketwatch.com
#TechBio #company #public #IPO #demand #spreads #biotech
This ‘AI TechBio’ company goes public as IPO demand spreads to biotech
